you are here:

Dr Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE089A01023 | SECTOR: Pharmaceuticals

BSE Live

Apr 22, 16:00
5199.70 45.75 (0.89%)
Volume
AVERAGE VOLUME
5-Day
117,845
10-Day
106,375
30-Day
58,614
118,493
  • Prev. Close

    5153.95

  • Open Price

    5195.00

  • Bid Price (Qty.)

    5185.00 (1)

  • Offer Price (Qty.)

    5199.70 (19)

NSE Live

Apr 22, 15:59
5199.85 43.10 (0.84%)
Volume
AVERAGE VOLUME
5-Day
2,067,594
10-Day
2,092,536
30-Day
1,244,886
2,424,134
  • Prev. Close

    5156.75

  • Open Price

    5179.95

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    5199.85 (784)

Financials

2020 2019 2018 2017 2016
Quarterly Results of Dr Reddys Laboratories (in Rs. Cr.) Dec '20 Sep '20 Jun '20 Mar '20 Dec '19  
Net Sales/Income from operations 3,408.20 3,333.60 3,236.80 2,837.90 3,044.00  
Other Operating Income -- 12.20 7.60 13.80 --  
Total Income From Operations 3,408.20 3,345.80 3,244.40 2,851.70 3,044.00  
EXPENDITURE  
Consumption of Raw Materials 845.30 816.50 788.20 654.30 673.00  
Purchase of Traded Goods 321.10 304.30 300.30 226.10 346.10  
Increase/Decrease in Stocks -87.70 -135.80 -192.90 67.20 -100.10  
Power & Fuel -- -- -- -- --  
Employees Cost 571.50 608.00 545.00 516.60 511.20  
depreciat 212.40 214.20 197.70 192.30 195.80  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- 936.20 -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 984.00 -- 875.10 866.70 858.10  
P/L Before Other Inc. , Int., Excpt. Items & Tax 561.60 602.40 731.00 328.50 559.90  
Other Income 62.80 26.60 644.70 127.40 69.30  
P/L Before Int., Excpt. Items & Tax 624.40 629.00 1,375.70 455.90 629.20  
Interest 6.50 9.30 14.00 11.80 11.70  
P/L Before Exceptional Items & Tax 617.90 619.70 1,361.70 444.10 617.50  
Exceptional Items -- -- -- -- --  
P/L Before Tax 617.90 619.70 1,361.70 444.10 617.50  
Tax 174.20 138.70 411.50 -58.70 95.80  
P/L After Tax from Ordinary Activities 443.70 481.00 950.20 502.80 521.70  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- --  
Net Profit/(Loss) For the Period 443.70 481.00 950.20 502.80 521.70  
Equity Share Capital 83.10 83.10 83.10 83.10 83.10  
Reserves Excluding Revaluation Reserves -- -- -- -- --  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS 26.74 29.00 57.31 30.34 31.47  
Diluted EPS 26.66 28.92 57.18 30.28 31.42  
EPS After Extra Ordinary  
Basic EPS. 26.74 29.00 57.31 30.34 31.47  
Diluted EPS. 26.66 28.92 57.18 30.28 31.42  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores). -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group). -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company). -- -- -- -- --  
Source : Dion Global Solutions Limited

Results of Dr Reddys Labs